155 related articles for article (PubMed ID: 4562533)
1. [Pathogenesis and manifestation of disturbances of erythropoiesis and granulopoiesis in myeloproliferative syndromes].
Meuret G; Hoffmann G
Klin Wochenschr; 1972 Sep; 50(18):853-61. PubMed ID: 4562533
[No Abstract] [Full Text] [Related]
2. Secondary gout associated with chronic myeloproliferative disorders.
Yu T; Weinreb N; Wittman R; Wasserman LR
Semin Arthritis Rheum; 1976 Feb; 5(3):247-56. PubMed ID: 1062009
[No Abstract] [Full Text] [Related]
3. Polycythemia vera, myeloid metaplasia with terminal myelogenous leukemia.
LITWINS J; GREENWALD L; GREENWALD HP
Bulletin NY Med Coll; 1955; 18():38-45. PubMed ID: 13329577
[No Abstract] [Full Text] [Related]
4. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
[No Abstract] [Full Text] [Related]
5. [Metamorphosis of chronic myeloproliferative diseases].
Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
[No Abstract] [Full Text] [Related]
6. Abnormal myelopoietic clones in man.
McCulloch EA
J Natl Cancer Inst; 1979 Oct; 63(4):883-92. PubMed ID: 384008
[No Abstract] [Full Text] [Related]
7. The relationship of erythromonocytic leukemia to other myeloproliferative disorders.
Shaw MT; Bottomley SS; Bottomley RH; Hussein KK
Am J Med; 1973 Oct; 55(3):542-8. PubMed ID: 4355172
[No Abstract] [Full Text] [Related]
8. Von Recklinghausen neurofibromatosis and myeloproliferative disorders in adults.
Lightman SM
Lancet; 1988 Nov; 2(8621):1197-8. PubMed ID: 2903408
[No Abstract] [Full Text] [Related]
9. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
[No Abstract] [Full Text] [Related]
10. [MYELOPROLIFERATIVE SYNDROMES].
PIRESWDA F
Folha Med; 1964 Apr; 48():195-201. PubMed ID: 14271209
[No Abstract] [Full Text] [Related]
11. THE MYELOPROLIFERATIVE DISORDERS.
ISRAUELS MC
Scott Med J; 1965 Jun; 10():225-34. PubMed ID: 14337320
[No Abstract] [Full Text] [Related]
12. Folate deficiency in the myeloproliferative disorders.
Chanarin I
Am J Clin Nutr; 1970 Jun; 23(6):855-60. PubMed ID: 5431049
[No Abstract] [Full Text] [Related]
13. Chronic myeloproliferative diseases.
de Lacerda JF; Oliveira SN; Ferro JM
Handb Clin Neurol; 2014; 120():1073-81. PubMed ID: 24365372
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of acute leukaemia in myeloproliferative disorders.
Rosenthal DS; Moloney WC
Br J Haematol; 1977 Jul; 36(3):373-82. PubMed ID: 268210
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cells (third of three parts).
Quesenberry P; Levitt L
N Engl J Med; 1979 Oct; 301(16):868-72. PubMed ID: 384249
[No Abstract] [Full Text] [Related]
16. Uncontrolled thrombocytosis in chronic myeloproliferative disorders.
Kessler CM; Klein HG; Havlik RJ
Br J Haematol; 1982 Jan; 50(1):157-67. PubMed ID: 6976793
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of platelet function in the myeloproliferative disorders.
Cardamone JM; Edson JR; McArthur JR; Jacob HS
JAMA; 1972 Jul; 221(3):270-3. PubMed ID: 4504007
[No Abstract] [Full Text] [Related]
18. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS].
KUNZ G
Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899
[No Abstract] [Full Text] [Related]
19. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
Kaufman S; Brière J; Bernard J
Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
[TBL] [Abstract][Full Text] [Related]
20. Chorea with transitional myeloproliferative disease.
Coppack SW; Gibberd FB
J R Soc Med; 1985 Oct; 78(10):864-6. PubMed ID: 4045892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
